PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice.

Item

http://www.wikidata.org/entity/Q42281690

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

PEGylated helper-dependent ade ...... herapy in LDLR-deficient mice.

@en

PEGylated helper-dependent ade ...... herapy in LDLR-deficient mice.

@nl

type

Item

label

PEGylated helper-dependent ade ...... herapy in LDLR-deficient mice.

@en

PEGylated helper-dependent ade ...... herapy in LDLR-deficient mice.

@nl

prefLabel

PEGylated helper-dependent ade ...... herapy in LDLR-deficient mice.

@en

PEGylated helper-dependent ade ...... herapy in LDLR-deficient mice.

@nl

P1476

PEGylated helper-dependent ade ...... herapy in LDLR-deficient mice.

@en

P2093

B Lombardo

http://www.w3.org/2001/XMLSchema#string

C Mazzaccara

http://www.w3.org/2001/XMLSchema#string

D Astone

http://www.w3.org/2001/XMLSchema#string

E Leggiero

http://www.w3.org/2001/XMLSchema#string

G Labruna

http://www.w3.org/2001/XMLSchema#string

L Sacchetti

http://www.w3.org/2001/XMLSchema#string

M Croyle

http://www.w3.org/2001/XMLSchema#string

V Cerullo

http://www.w3.org/2001/XMLSchema#string

P2860

Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector

A new adenovirus based vaccine vector expressing an Eimeria tenella derived TLR agonist improves cellular immune responses to an antigenic target

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery

Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor.

Generation of helper-dependent adenoviral vectors by homologous recombination.

PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile.

Modulation of TNFalpha, a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors.

Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy.

P2888

gt.2013.38

P304

1124-1130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2013.38

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lucio Pastore

Francesco Salvatore

P577

2013-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1009690978

http://www.w3.org/2001/XMLSchema#string

P698

23883962

http://www.w3.org/2001/XMLSchema#string

P921

Adenoviridae

gene therapy